Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Recs

0
Player Avatar Stef100000 (< 20) Submitted: 4/10/2012 1:22:13 PM : Underperform Start Price: $1.42 KERX Score: -979.56

No future

Featured Broker Partners


Advertisement